Atlas Lithium Corp
For the period ended Dec 31, 2025. Filed Mar 4, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 4, 2026
ATLX$1.69+3.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statement of Stockholders’ Equity
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
For the Twelve Months Ended December 31, 2025 and 2024
| Series A Preferred Stock · Common Stock · Additional Paid-in · Accumulated Other Comprehensive · Cumulative Adjustment of the Valuation of Fin. · Accumulated · Noncontrolling · Total Stockholders’ Equity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares · Value · Shares · Value · Capital · Loss · Instruments · Deficit · Interests · (Deficit) | |||||||||||
| Balance, December 31, 2023 | 1 | $1 | 12,763,581 | $12,764 | $110,195,978 | $(138,829) | $ | - | $(102,822,123) | $427,302 | $7,675,093 |
| Issuance of common stock in connection with sales made under private offerings | - | - | 2,062,973 | 2,063 | 31,313,878 | - | - | - | 1,600,700 | 32,916,641 | |
| Issuance of common stock in exchange for consulting, professional and other services | - | - | 36,000 | 36 | 398,977 | - | - | - | - | 399,013 | |
| Exercise of warrants | 1,115,862 | 1,116 | 3,000 | - | - | - | - | 4,116 | |||
| Stock based compensation | - | - | 36,326 | 36 | 24,199,083 | - | - | - | 1,788,321 | 25,987,440 | |
| Adjustment of the Valuation of Fin. Instruments | - | - | - | - | - | - | (278,820) | - | - | (278,820) | |
| Other changes in Noncontrolling interest | - | - | - | - | - | - | - | 652,979 | (652,979) | - | |
| Change in foreign currency translation | - | - | - | - | - | (41,161) | - | - | (237,859) | (279,020) | |
| Net loss | - | - | - | - | - | - | - | (42,241,196) | (2,172,026) | (44,413,222) | |
| Balance, December 31, 2024 | 1 | $1 | 16,014,742 | $16,015 | $166,110,916 | $(179,990) | $(278,820) | $(144,410,340) | $753,459 | $22,011,241 | |
| Series A Preferred Stock · Common Stock · Additional Paid-in · Accumulated Other Comprehensive · Cumulative Adjustment of the Valuation of Fin. · Accumulated · Noncontrolling · Total Stockholders’ Equity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares · Value · Shares · Value · Capital · Loss · Instruments · Deficit · Interests · (Deficit) | |||||||||||
| Balance, December 31, 2024 | 1 | $1 | 16,014,742 | $16,015 | $166,110,916 | $(179,990) | $(278,820) | $(144,410,340) | $753,459 | $22,011,241 | |
| Issuance of common stock in connection with sales made | 10,127,566 | 10,128 | 49,862,904 | - | - | - | 2,516,900 | 52,389,932 | |||
| under public offerings | - | - | - | - | - | - | - | - | - | - | |
| Exercise of warrants | - | - | - | - | - | - | - | - | - | - | |
| Stock based compensation | 826,193 | 826 | 7,437,662 | - | - | - | 1,923,216 | 9,361,704 | |||
| Adjustment of the Valuation of Fin. Instruments | - | - | - | - | - | - | 503,725 | - | - | 503,725 | |
| Other changes in Noncontrolling interest | - | - | - | - | - | - | - | 950,030 | (950,030) | - | |
| Change in foreign currency translation | - | - | - | - | - | 38,050 | - | - | 126,493 | 164,543 | |
| Net loss | - | - | - | - | - | - | ) | - | (28,110,592) | (3,791,273) | (31,901,865) |
| Balance, December 31, 2025 | 1 | $1 | 26,968,501 | $26,969 | $223,411,482 | $(141,940) | $224,905 | $(171,570,902) | $578,765 | $52,529,280 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.